TraceLink reports a transformative 2025, unveiling plans to advance beyond connectivity towards fully autonomous, AI-enabled, multienterprise operations in the regulated life sciences supply chain in 2026, amid growing industry regulation and digitalisation efforts.
As the life sciences sector confronts tighter regulation, supply volatility and rapid AI adoption, TraceLink says it completed a transformational year in 2025 and is now positioning its platform to move beyo...
Continue Reading This Article
Enjoy this article as well as all of our content, including reports, news, tips and more.
By registering or signing into your SRM Today account, you agree to SRM Today's Terms of Use and consent to the processing of your personal information as described in our Privacy Policy.
nd connectivity toward automated, multienterprise execution in 2026. According to TraceLink, the company’s advances in regulated data exchange, no-code orchestration and networked transactions have created the conditions for what it describes as “agentic” supply‑chain operations.
Shabbir Dahod, TraceLink’s president and chief executive officer, said: “Digitalization and the operational deployment of AI across one of the world’s most valuable and least automated industries represents a generational opportunity.” He added the company is building a foundation of “trusted network data, regulated infrastructure, and end-to-end orchestration”.
The company highlights its role in meeting a pivotal regulatory deadline in the United States. According to TraceLink, by the time the Drug Supply Chain Security Act dispenser requirement took effect on 27 November 2025 the platform had enabled more than 26,000 organisations for compliance, activated roughly 300 new DSCSA live links each week during peak periods and processed billions of serialized EPCIS transaction events. TraceLink says those regulated exchanges now act as an auditable transaction backbone that customers are repurposing for wider operational coordination.
TraceLink reports its business network links hundreds of thousands of trading partners worldwide and is seeing users expand use of its Orchestration Platform for Universal Solutions (OPUS) and the Multienterprise Information Network Tower (MINT) into commercial, logistics and manufacturing workflows. The company states MINT achieved steep expansion in 2025, with large percentage increases in customers, link onboarding and live transaction types, while OPUS now supports more than 60 standardised transaction types and 65 collaborative processes together with a suite of pre‑configured, no‑code reports and dashboards.
Those platform capabilities, TraceLink says, have already been applied across common shared processes such as order management, production execution, inventory and materials control, shipment coordination and recall management. The firm reports the network now handles in excess of 7 billion regulated transactions annually and that customers ran 182 live transaction types in production across five core business orchestrations during 2025.
Industry recognition has followed that expansion. According to TraceLink, independent certifications and third‑party audits in 2025 reinforced its governance and security posture, including ISO 27001, ISO 27017 and ISO 9001 certifications, SOC 2 Type II and SOC 1 attestations, and a CyberVadis Platinum rating. The company also cites external awards: MINT was named “Supply Chain Transparency Solution of the Year” in the 2025 SupplyTech Breakthrough Awards, and TraceLink was recognised as “Supply Chain Orchestration Company of the Year 2025” by Logistics Tech Outlook.
TraceLink frames these developments as preparatory work for embedding governed AI agents into real, multienterprise transactions. The firm says OPUS now provides the structured, auditable information layer and no‑code tooling required to permit autonomous agents to act across partner workflows while operating inside regulated, GxP environments.
Analysts and customers who have been quoted in TraceLink’s releases point to faster integration and lower project complexity as immediate benefits of the platform’s “integrate once” approach. According to the company, the expanding catalogue of standardised transaction types and enterprise integrations is reducing the time and cost of digitalisation for participants across the network.
While TraceLink depicts 2025 as the year its infrastructure moved from mere connectivity to execution at scale, the company’s statements also underline that widespread agentic orchestration remains nascent and will depend on continued adoption across manufacturers, distributors, pharmacies and logistics providers. According to TraceLink, the coming phase will be defined less by adding connectors and more by converting verified, networked data into reliable, automated actions that preserve regulatory compliance and auditability.
Whether customers accelerate that shift will hinge on commercial priorities, investment cycles and regulators’ tolerance for AI‑driven process execution in regulated supply chains. TraceLink says it enters 2026 with an expanded product set, deeper network effects and third‑party validations that, in its view, position the platform to support governed, AI‑enabled execution across the global life sciences and healthcare supply chain.
Source: Noah Wire Services
